The PEX14 Gene Zellweger Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the PEX14 gene, which are linked to Zellweger Syndrome, a rare genetic disorder. This condition falls under the spectrum of peroxisome biogenesis disorders and is characterized by the impairment of multiple systems in the body, including the brain, liver, and kidneys. Early detection through genetic testing can provide crucial information for managing the syndrome, allowing for tailored treatments and interventions.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the PEX14 gene to uncover any genetic abnormalities that could indicate the presence of Zellweger Syndrome. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed using advanced genetic sequencing techniques to identify mutations.
The cost of the PEX14 Gene Zellweger Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the intricate processes involved in genetic analysis and the specialized expertise required to interpret the results accurately. For families and individuals facing the possibility of Zellweger Syndrome, this test represents a critical step towards understanding the condition and planning for the necessary medical and supportive care.
The PEX16 Gene Zellweger Syndrome Genetic Test is a specialized diagnostic assessment designed to detect mutations in the PEX16 gene, which are associated with Zellweger Syndrome, a rare genetic disorder. This condition belongs to a group of diseases known as peroxisome biogenesis disorders, characterized by the body's inability to properly form peroxisomes, leading to severe metabolic complications. The PEX16 gene plays a crucial role in the formation of peroxisomes, and mutations in this gene can disrupt cellular processes, resulting in the symptoms observed in Zellweger Syndrome, which include developmental delays, neurological issues, and abnormalities in liver and kidney function.
Conducted at DNA Labs UAE, a leading genetic testing facility known for its advanced diagnostic technologies and expertise in genetic analysis, this test offers families and individuals critical information regarding the genetic underpinnings of Zellweger Syndrome. The test is priced at 4400 AED, reflecting the sophisticated nature of the genetic analysis and the specialized expertise required to interpret the results. Through a simple blood sample, the test aims to provide conclusive evidence of the presence or absence of mutations in the PEX16 gene, offering invaluable insights for affected families. This information can guide treatment decisions, inform family planning, and connect families with appropriate support and resources for managing the condition.
The PEX19 gene test for Zellweger Syndrome is a genetic examination aimed at identifying mutations in the PEX19 gene, which is crucial for the proper functioning of peroxisomes. These cellular components are essential for various metabolic processes, including the breakdown of fatty acids. Mutations in the PEX19 gene can lead to Zellweger Syndrome, a rare, inherited condition characterized by severe abnormalities in the brain, liver, and kidneys, along with distinctive facial features.
Zellweger Syndrome is part of a spectrum of peroxisomal biogenesis disorders, and early diagnosis is vital for managing symptoms and providing supportive care. The test involves analyzing the patient's DNA to identify any genetic alterations in the PEX19 gene that may be responsible for the syndrome.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the PEX19 gene test for Zellweger Syndrome is priced at 4400 AED. The test is designed for individuals with a clinical suspicion of Zellweger Syndrome or those with a family history of the condition, aiming to provide crucial information for diagnosis, management, and genetic counseling.
The PEX2 Gene Zellweger Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PEX2 gene that are associated with Zellweger Syndrome, a rare genetic disorder. This test is critical for the early detection and management of the syndrome, which affects multiple systems in the body and is characterized by abnormalities in the brain, liver, and kidneys, among other symptoms. The cost of the test is 4400 AED, making it a valuable investment for families with a history of the disorder or for those seeking a diagnosis for observed symptoms consistent with Zellweger Syndrome. Conducted in the advanced facilities of DNA Labs UAE, the test offers a comprehensive analysis, providing essential information for healthcare providers to develop an appropriate care plan for affected individuals.
The PEX26 Gene Zellweger Syndrome Genetic Test is a specialized diagnostic tool used to detect mutations in the PEX26 gene, which is crucial for diagnosing Zellweger Syndrome, a rare, inherited disorder characterized by the absence or malfunction of peroxisomes in the cells of the body. This condition leads to a spectrum of medical issues, including impairments in the brain, liver, and kidneys, and affects physical and mental development.
The test is conducted by DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab to identify any genetic alterations in the PEX26 gene.
The cost of the PEX26 Gene Zellweger Syndrome Genetic Test is 4400 AED. This investment is crucial for families seeking answers to health questions related to Zellweger Syndrome, as early detection and understanding of the specific genetic mutation can guide treatment options, manage symptoms, and improve the quality of life for affected individuals.
The PEX6 Gene Zellweger Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the PEX6 gene, which are linked to Zellweger Syndrome. Zellweger Syndrome is a rare, inherited disorder characterized by the reduction or absence of peroxisomes in the cells of the body, leading to a spectrum of medical issues including abnormalities in the brain, liver, and kidneys, as well as developmental delays. The test is crucial for early diagnosis and management of the condition, providing essential genetic information that can guide treatment plans and inform family planning decisions. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the presence of PEX6 gene mutations. Conducted at DNA Labs UAE, this test is an important tool for families and individuals at risk of Zellweger Syndrome, offering hope for better management of the condition through early detection and intervention.
The CYP17A1 gene plays a crucial role in the production of steroid hormones in the body, including cortisol, androgens, and estrogens. A deficiency in the 17-hydroxylation activity, governed by the CYP17A1 gene, can lead to a rare genetic condition that affects steroid hormone biosynthesis. This condition can manifest in various ways, including adrenal insufficiency and disorders of sex development, depending on the specific mutations in the CYP17A1 gene and the extent of enzyme activity impairment.
To diagnose this condition, a genetic test can be conducted to identify mutations in the CYP17A1 gene that are responsible for the deficiency in 17-hydroxylation activity. DNA Labs UAE offers this specialized genetic test, providing a crucial tool for the diagnosis and management of conditions arising from CYP17A1 gene mutations. The test is priced at 4400 AED and involves collecting a DNA sample from the patient, which is then analyzed for specific genetic mutations associated with the enzyme deficiency.
By accurately diagnosing the genetic basis of the condition, healthcare providers can tailor treatment and management plans to address the specific needs of the patient, potentially improving outcomes and quality of life for those affected by this rare genetic disorder.
The DECR1 Gene 24-Dienoyl-CoA Reductase 1 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at identifying mutations in the DECR1 gene. This gene plays a critical role in the metabolism of very long-chain fatty acids by encoding an enzyme involved in the beta-oxidation pathway. Mutations in the DECR1 gene can lead to metabolic disorders that may impact an individual's health significantly.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed in the laboratory to detect any genetic variations in the DECR1 gene that may indicate a predisposition to related metabolic conditions. This genetic test is crucial for early diagnosis and management of potential metabolic issues, providing essential information for personalized treatment plans.
DNA Labs UAE, where this test is conducted, utilizes advanced genetic testing technologies to ensure accurate and reliable results. The test is recommended for individuals with a family history of metabolic disorders or those exhibiting symptoms related to abnormal fatty acid metabolism. By identifying genetic mutations early, patients can take proactive steps towards managing their health, guided by their healthcare provider's recommendations based on the test results.
The NADK2 Gene 24-Dienoyl-CoA Reductase Deficiency Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the NADK2 gene. This gene plays a crucial role in the metabolism of fatty acids and energy production within the body. Mutations in the NADK2 gene can lead to a rare metabolic disorder known as 24-Dienoyl-CoA Reductase Deficiency. This condition can result in a variety of symptoms, including developmental delays, muscle weakness, and metabolic crises, making early detection and management essential for affected individuals.
The test is performed using a blood sample from the patient, which is then analyzed using advanced genetic sequencing techniques to identify any mutations in the NADK2 gene. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, this test offers a critical resource for families seeking answers to complex metabolic disorders. By identifying the genetic basis of the condition, the test can guide treatment decisions and provide valuable information for family planning.
The DHTKD1 Gene 2-Aminoadipic 2-Oxoadipic Aciduria Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE. This test is designed to identify mutations in the DHTKD1 gene, which have been associated with 2-Aminoadipic 2-Oxoadipic Aciduria, a rare metabolic disorder. The condition is characterized by the accumulation of certain compounds in the urine, leading to various metabolic issues. Individuals with this disorder may experience a range of symptoms, including developmental delay, muscle weakness, and potential neurological implications.
The test involves a detailed analysis of the DHTKD1 gene to pinpoint any genetic alterations that may contribute to the disorder. By identifying these mutations, healthcare providers can offer more accurate diagnoses, tailor treatment plans to the individual's genetic profile, and offer genetic counseling to families.
The cost of the DHTKD1 Gene 2-Aminoadipic 2-Oxoadipic Aciduria Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, which employs advanced genetic sequencing technologies to ensure accurate and reliable results. Conducting the test at DNA Labs UAE ensures that patients receive support from a team of genetic specialists and counselors, who can assist in interpreting the results and guiding subsequent steps for management or treatment of the condition.
